|
| 36250964 | Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma. | Pediatr Blood Cancer | 2023 |
| 35027427 | Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors. | J Immunother Cancer | 2022 |
| 35727602 | Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma. | Clin Cancer Res | 2022 |
| 35657346 | Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium. | Mol Cancer Ther | 2022 |
| 35312779 | Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma. | Mol Cancer Ther | 2022 |
| 32804009 | Initial <i>in vivo</i> testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium. | Pediatr Hematol Oncol | 2021 |
| 34029149 | Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial. | Cancer Control | 2021 |
| 33298592 | ABBV-085, Antibody-Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium. | Mol Cancer Ther | 2021 |
| 32207565 | Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium. | Pediatr Blood Cancer | 2020 |
| 32706456 | Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium. | Pediatr Blood Cancer | 2020 |
| 31208461 | Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile. | J Immunother Cancer | 2019 |
| 31693904 | Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. | Cell Rep | 2019 |
| 29560102 | Detection of circulating tumor DNA in patients with osteosarcoma. | Oncotarget | 2018 |
| 30250282 | Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma. | Sci Rep | 2018 |
| 29152125 | CD49b inhibits osteogenic differentiation and plays an important role in osteosarcoma progression. | Oncotarget | 2017 |
| 28435520 | Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model. | Genes Cancer | 2017 |
| 28264040 | The effect of bone morphogenetic protein-2 on osteosarcoma metastasis. | PLoS One | 2017 |
| 27744117 | Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R). | Nucl Med Biol | 2016 |
| 27863409 | Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma. | Oncotarget | 2016 |
| 25472999 | Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2. | Clin Cancer Res | 2015 |
| 24826055 | Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Macao. | Chin J Cancer Res | 2014 |
| 25363316 | Tea intake and risk of oral, pharyngeal, and laryngeal carcinoma: a meta-analysis. | Med Sci Monit | 2014 |
| 23436047 | Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma. | Tumour Biol | 2013 |
| 23125530 | β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells. | Sarcoma | 2012 |
| 21472724 | Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts. | Cancer | 2011 |
| 20486173 | R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts. | Pediatr Blood Cancer | 2010 |
| 19224214 | Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma. | Cancer Chemother Pharmacol | 2009 |
| 19593798 | Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential. | Cancer | 2009 |
| 19447875 | Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo. | Clin Cancer Res | 2009 |
| 17066459 | The pediatric preclinical testing program: description of models and early testing results. | Pediatr Blood Cancer | 2007 |
| 17875774 | Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma. | Clin Cancer Res | 2007 |